北京时间2011年3月30日，香格里拉藏药（TBET，4.51，+2.27%） 公布了截至2010年12月31日的全年财报。财报披露主要数据如下：
营业收入3240万美元，较2009年2300万美元同比增长41%；
毛利润1620万美元，较2009年1170万同比增长38%；
净利润1310万美元，较2009年920万同比增长42%；
2010财年摊薄后每股收益1.11美元，创历史新高。
Tibet Pharmaceuticals Reports Record Financial Results for Fiscal Year Ended December 31, 2010 --Revenue for Fiscal Year December 31 Increases 41% to $32.4 Million --Net Income Rises 42% to $13.1 Million Resulting in $1.11 Fully Diluted EPS --Earnings Conference Call Scheduled for Friday, April 1 at 10:00 am Eastern
SHANGRI-LA COUNTY, China
, March 30, 2011 /PRNewswire via COMTEX News Network/ --
Tibet Pharmaceuticals, Inc. (Nasdaq:TBET), an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in China, today reported record financial results
for its fiscal year ended December 31, 2010.
Summary of Fiscal Year
Ended December 31, 2010 Financial Results:
Revenue of $32.4 million, an increase of 41% from $23.0 million in 2009
Gross profit of $16.2 million, an increase of 38% from $11.7 million in 2009
Net income of $13.1 million, an increase of 42% from $9.2 million in 2009
Fully diluted EPS of $1.11 for fiscal 2010, exceeding all prior results